泰利克斯制药 TLX
$9.63 +$0.21 (+2.23%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $9.63 0.00%
开盘$9.42
昨收$9.42
当日区间$9.42 – $9.71
成交量311.8K
市值$3.26B
市盈率（TTM）99.3
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例48.8%+1.07 个百分点，较上季度
持仓机构数147+4 ，较上季度
内部人近期交易3次买入 / 0次卖出净买入
空头持仓比例0.10% 占流通股回补天数 1.1 · 截至 15 Oct 2026
卖空成交量占比21.5%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$460.5K（12个净流入日，8个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有35.1%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已基本持稳于0.10%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +950,408 | 0.8% |
| Vanguard Investments Australia Limited | Mutual Fund | 2026/Q3 | +180,786 | 1.9% |
| BetaShares Capital Limited | Mutual Fund | 2026/Q3 | +123,546 | 0.6% |
| Aubrey Capital Management Limited | Mutual Fund | 2026/Q3 | +105,000 | 0.0% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +100,696 | 3.1% |
| Hennion & Walsh Asset Management, Inc. | Mutual Fund | 2026/Q3 | +65,718 | 0.1% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +871,964 | 0.8% |
| Vanguard Asset Management, Limited | Mutual Fund | 2026/Q3 | +66,893 | 0.2% |
| Van Eck Associates Corporation | Mutual Fund | 2026/Q3 | +49,637 | 0.2% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +47,292 | 3.1% |
| Vanguard Investments Australia Limited | Mutual Fund | 2026/Q3 | +70,005 | 1.9% |
| Vanguard Asset Management, Limited | Mutual Fund | 2026/Q3 | +46,078 | 0.2% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +4,181,551 | 9.0% |
| Candriam, Société En Commandite Par Actions | Mutual Fund | 2026/Q3 | +402,176 | 0.4% |
| Strategic Advisers LLC | Mutual Fund | 2026/Q3 | +332,622 | 0.3% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 6 Sep 2026 | Darren Smith | Group Chief Financial Officer | Private Acquisition | +2,071 | $9.66 | 13,992 |
| 28 Apr 2026 | Christian Behrenbruch | Co-Founder, MD, Group CEO & Executive Director | Open Market Acquisition | +67,935 | $14.87 | 20,996,941 |
| 28 Mar 2026 | Darren Smith | Group Chief Financial Officer | Derivative Exercise and Retained | +1,111 | – | 11,921 |
| 17 Mar 2026 | David Cade | Group Chief Medical Officer | Initial Statement of Beneficial | +0 | – | 12,566 |
| 17 Mar 2026 | Darren Smith | Group Chief Financial Officer | Initial Statement of Beneficial | +0 | – | 15,852 |
| 17 Mar 2026 | Mark Nelson | Independent Non-Executive Director | Initial Statement of Beneficial | +0 | – | 3,628,750 |
| 17 Mar 2026 | Christian Behrenbruch | Co-Founder, MD, Group CEO & Executive Director | Initial Statement of Beneficial | +0 | – | 2,595 |
| 17 Mar 2026 | Jann Skinner | Independent Non-Executive Director | Initial Statement of Beneficial | +0 | – | 595,000 |
| 17 Mar 2026 | Darren Patti | Group Chief Operating Officer | Initial Statement of Beneficial | +0 | – | 804 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 352,936 | 0.1% | 1.1 |
| 30 Sep 2026 | 426,829 | 0.1% | 1.0 |
| 15 Sep 2026 | 352,524 | 0.1% | 1.0 |
| 31 Aug 2026 | 264,943 | 0.1% | 1.8 |
| 14 Aug 2026 | 244,900 | 0.1% | 2.3 |
| 31 Jul 2026 | 277,664 | 0.1% | 2.6 |
暂无评论——快来第一个聊聊 TLX。
登录后参与讨论。